P. Koczurkiewicz-Adamczyk

M. Kołaczkowski, H. Marona, A. Gunia-Krzyżak, 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

S(+)-(2E)-N-(2-Hydroxypropyl)-3-Phenylprop-2-Enamide (KM-568): A Novel Cinnamamide Derivative with Anticonvulsant Activity in Animal Models of Seizures and Epilepsy

H. Marona, A. Gunia-Krzyżak, D. Żelaszczyk, 2020, International journal of molecular sciences.

Pyridine derivatives as candidates for selective and sensitive fluorescent biosensors for lung cancer cell imaging and iron ions detection

P. Fiedor, D. Bogdał, J. Ortyl, 2022, Dyes and Pigments.

2-Phenyl-1H-pyrrole-3-carboxamide as a New Scaffold for Developing 5-HT6 Receptor Inverse Agonists with Cognition-Enhancing Activity

M. Pawłowski, A. Bojarski, P. Marin, 2021, ACS chemical neuroscience.

Pan-Phosphodiesterase Inhibitors Attenuate TGF-β-Induced Pro-Fibrotic Phenotype in Alveolar Epithelial Type II Cells by Downregulating Smad-2 Phosphorylation

R. Gosens, E. Wyska, E. Pękala, 2022, Pharmaceuticals.

Carbonyl Reduction Pathway in Hepatic In Vitro Metabolism of Anthracyclines: Impact of Structure on Biotransformation Rate.

M. Kołaczkowski, Adam Bucki, E. Pękala, 2021, Toxicology letters.

Anticonvulsant and analgesic in neuropathic pain activity in a group of new aminoalkanol derivatives.

Iwona Skiba-Kurek, E. Karczewska, A. Waszkielewicz, 2020, Bioorganic & medicinal chemistry letters.

In silico and in vitro ADME-Tox analysis and in vivo pharmacokinetic study of representative pan-PDE inhibitors from the group of 7,8-disubstituted derivatives of 1,3-dimethyl-7H-purine-2,6-dione.

E. Wyska, E. Pękala, K. Piska, 2022, Toxicology and applied pharmacology.

Antidepressant pharmaceuticals in aquatic systems, individual-level ecotoxicological effects: growth, survival and behavior.

A. Gunia-Krzyżak, E. Pękala, K. Słoczyńska, 2023, Aquatic toxicology.

In Silico and In Vitro Assessment of Carbonyl Reductase 1 Inhibition Using ASP9521—A Potent Aldo-Keto Reductase 1C3 Inhibitor with the Potential to Support Anticancer Therapy Using Anthracycline Antibiotics

M. Kołaczkowski, B. Władyka, Adam Bucki, 2023, Molecules.

1-(Arylsulfonyl-isoindol-2-yl)piperazines as 5-HT6R Antagonists: Mechanochemical Synthesis, In Vitro Pharmacological Properties and Glioprotective Activity

A. Bojarski, P. Marin, G. Satała, 2022, Biomolecules.

Imidazopyridine-Based 5-HT6 Receptor Neutral Antagonists: Impact of N1-Benzyl and N1-Phenylsulfonyl Fragments on Different Receptor Conformational States.

A. Bojarski, P. Marin, Rafał Kurczab, 2021, Journal of Medicinal Chemistry.

Inhaled pan-phosphodiesterase inhibitors ameliorate ovalbumin-induced airway inflammation and remodeling in murine model of allergic asthma.

R. Gosens, E. Wyska, E. Pękala, 2023, International immunopharmacology.

Synthesis and in vitro evaluation of anti-inflammatory, antioxidant, and anti-fibrotic effects of new 8-aminopurine-2,6-dione-based phosphodiesterase inhibitors as promising anti-asthmatic agents.

R. Gosens, E. Wyska, E. Pękala, 2021, Bioorganic chemistry.

Comparative study on ABCB1-dependent efflux of anthracyclines and their metabolites: consequences for cancer resistance

M. Kołaczkowski, Adam Bucki, E. Pękala, 2023, Xenobiotica; the fate of foreign compounds in biological systems.

5-HT6 receptor neutral antagonists protect astrocytes: A lesson from 2-phenylpyrrole derivatives.

A. Bojarski, Rafał Kurczab, G. Satała, 2024, European journal of medicinal chemistry.

Aclarubicin: contemporary insights into its mechanism of action, toxicity, pharmacokinetics, and clinical standing

E. Pękala, K. Piska, Bartosz Gąsiorkiewicz, 2024, Cancer chemotherapy and pharmacology.